March 5, 2026 · Form 4 insider transaction
MAHON PAUL A bought 8,300 shares of United Therapeutics Corporation at $146.03 per share, a transaction worth $1.21M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.; Includes 63 shares of common stock acquired on March 4, 2026 under the United Therapeutics Employee Stock Purchase Plan.